Teva Women's Health Inc. today reported positive results from the Phase III clinical trial of its Quartette oral contraceptive. The study found that Quartette was effective and has a safety profile similar to that of other oral contraceptives. The clinical trial enrolled 3,701 sexually active women...
FULL ARTICLE AT Globes Online